Steering anti-cancer drugs away from the TRAIL

被引:0
|
作者
Shigekazu Nagata
机构
[1] Osaka University Medical School and Core Research for Evolutional Science and Technology,Department of Genetics
[2] Japan Science and Technology Corporation,undefined
来源
Nature Medicine | 2000年 / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
TRAIL, a cytokine of the TNF family, has been hyped as an almost ‘magical’ drug for cancer treatment. However, its possible side effects in the liver raise serious concerns about its likelihood for development into a safe therapeutic product (pages 564–567 ).
引用
收藏
页码:502 / 503
页数:1
相关论文
共 50 条
  • [41] PROBLEMS OF TOXICITY OF ANTI-CANCER DRUGS
    YOUNG, RSK
    FEDERATION PROCEEDINGS, 1979, 38 (01) : 113 - 114
  • [42] Optional copayments on anti-cancer drugs
    van de Vooren, Katelijne
    Curto, Alessandro
    Garattini, Livio
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [43] SORBENT REMOVAL OF ANTI-CANCER DRUGS
    RAHMAN, A
    WINCHESTER, JF
    KESSLER, A
    SLAVIK, M
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 233 - 233
  • [44] PHARMACOKINETICS OF ANTI-CANCER DRUGS IN CHILDREN
    EVANS, WE
    CROM, WR
    SINKULE, JA
    YEE, GC
    STEWART, CF
    HUTSON, PR
    DRUG METABOLISM REVIEWS, 1983, 14 (05) : 847 - 886
  • [45] Liposomal encapsulated anti-cancer drugs
    Hofheinz, RD
    Gnad-Vogt, SU
    Beyer, U
    Hochhaus, A
    ANTI-CANCER DRUGS, 2005, 16 (07) : 691 - 707
  • [46] Taxanes: Promising Anti-Cancer Drugs
    Fauzee, Nilufer Jasmine Selimah
    Dong, Zhi
    Wang, Ya-lan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (04) : 837 - 851
  • [47] Tissue transport of anti-cancer drugs
    Lankelma, J
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (22) : 1987 - 1993
  • [48] Anaesthesia and anti-cancer chemotherapeutic drugs
    Huettemann, Egbert
    Sakka, Samir G.
    CURRENT OPINION IN ANESTHESIOLOGY, 2005, 18 (03) : 307 - 314
  • [49] Moving away from PPARs - EGFR signaling and the anti-cancer effects of thiazolinedinediones
    Jesse Roman
    Cell Research, 2009, 19 : 669 - 671
  • [50] Moving away from PPARs - EGFR signaling and the anti-cancer effects of thiazolinedinediones
    Roman, Jesse
    CELL RESEARCH, 2009, 19 (06) : 669 - 671